logo
logo
Sign in

Alzheimer’s Disease Diagnostic Market: 2020 Global Industry Share, Size, Key Players, Trends, Competitive And Regional Forecast To 2022

avatar
Sapana Supekar
Alzheimer’s Disease Diagnostic Market: 2020 Global Industry Share, Size, Key Players, Trends, Competitive And Regional Forecast To 2022

Alzheimer’s Disease Diagnostic Market Insight

The global Alzheimer’s disease diagnostic market is projected to attain revenues at the value of USD 12 billion by 2022, asserts Market Research Future (MRFR). The market is set to inflate ahead at a CAGR of 10% during the forecast period till 2022.

Alzheimer’s is considered as a type of dementia, which results in memory loss accompanied by problems incurred by thinking and behavior process. Alzheimer's is a progressive disease which is gradually increasing with time and damages in the maximum part of the brain by destroying brain cells. The study observed that the maximum incidence of this disease is in the UK where more than 520,000 people are diagnosed with Alzheimer's disease and the increasing aging population is the critical factor driving Alzheimer’s disease diagnostic market.

Alzheimer’s Disease Diagnostic Market Drivers & Trends

Growing prevalence of geriatric population has boomed the Alzheimer's disease cases in recent time, which has bolstered the market growth. By this, there is an elevated demand for efficient diagnostic procedures, which results in the expansion of global Alzheimer's disease diagnostic market remarkably. The intensive efforts of the healthcare sector and by industry participants have done wonders for the market growth.

In recent time, the rise in healthcare expenditure mainly in developing and developed regions along with the development of multiple diagnostic tests is leading to the momentous growth of the global Alzheimer's disease diagnostic market during the forecast period. On the other hand, factors such as the development of effective biomarker technologies by the diagnostic technology companies for improvement in drug manufacturing are also impacting the market growth positively.

On the flip side, factors such as lack of awareness and low penetration of advanced diagnostic technologies in the underdeveloped regions can occur as restraints on the expansion of the global Alzheimer's disease diagnostic market during the assessment period.

Alzheimer’s Disease Diagnostic Market Segmentation

The segmentation of the Alzheimer’s disease diagnostic market has been done by type, diagnostic test, and end-users.

In terms of type, Alzheimer's disease diagnostic market includes early-onset Alzheimer's disease, late-onset Alzheimer's disease, familial Alzheimer's disease, and many others.

In terms of diagnostic test: it includes genetic testing, neurological exam, mini-mental state exam (MMSE), brain imaging, and others.

In terms of end-users: it includes clinics, hospitals, diagnostic centers, and many others.

Alzheimer’s Disease Diagnostic Market Detailed Regional Analysis

Geographically, the global Alzheimer's disease diagnostic market analysis is studied for the regions like North America, South America, Europe, Asia Pacific, and the Middle East and Africa. Among them, the North America region is anticipated to lead over the global Alzheimer's disease diagnostic market with the high prevalence of Alzheimer's disease and increasing research and development to amplify the accuracy of the diagnostic process.

Europe’s market is the second largest one for Alzheimer's disease diagnostic due to the rising healthcare expenditure in this region. The Asia Pacific region is then anticipated to project the fastest growth in the global Alzheimer's disease diagnostic market owing to the escalating awareness regarding Alzheimer's disease in this region.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149

Alzheimer’s Disease Diagnostic Market Key players

Eli Lilly and Company (the U.K.), TauRx (Republic of Singapore), Alector LLC (the U.S.), Accera, Inc. (the U.S.), Treventis Corporation (the U.S.), Neuro-Bio Ltd (the U.K.), Cognition Therapeutics Inc. (the U.S.) are some of the well-known players in the study presented by MRFR on the global Alzheimer’s disease diagnostic market.

collect
0
avatar
Sapana Supekar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more